Skip to main content
NVAX logo

NVAX

Novavax, Inc.

$9.26

2.32%

Trade Ideas Performance

Latest Closed Trade Idea

$9.26

2.32%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

73

Social

2

About

Events of Novavax, Inc. (NVAX)

In February 2026, Novavax reported a fourth-quarter profit and provided a 2026 revenue guidance between $230 million and $270 million. In April 2026, Shah Capital criticized Novavax's strategy and its failure to build sales of its COVID-19 vaccine. In May 2026, Novavax's shares rose after its Q1 2026 revenue beat analysts' estimates, attributed to milestone payments from vaccine supply and licensing agreements. The company announced a non-exclusive license agreement with Pfizer to utilize Matrix-M and reiterated its full-year 2026 revenue framework and target for non-GAAP profitability as early as 2028. The stock has risen 54% over the past year.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)